Latest filing published 05 Jun 2026 for 진양제약.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
최재준: trading record in brief
최재준 discloses dealings in 진양제약 to DART (FSS). Between 2 July 2025 and 5 June 2026, the trades on record add up to 3 filings.
Both buying and selling appear: 1 purchase, against 2 sales. No amount is published for 3 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings no purchases and 2 sales.
On 5 June 2026 came the latest disclosure, an open-market sale in 진양제약. The clock since the last published purchase (9 July 2025) now reads 489 days. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to 최재준
Open company profiles for insider transactions, fundamentals and analyst consensus when available.